Clinical Trial Update: The ePass Clinical Trial for the Treatment of Obese Subjects [NA]

View source ↗

Summary

Update on ValenTx, Inc.'s clinical trial of the ePass therapy for obesity; the current trial status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ePass

Snippet

Sponsor: ValenTx, Inc. | Conditions: Obesity | NA | Status: UNKNOWN